Brazil health regulator approves clinical trials of Oxford COVID-19 vaccine

  • 📰 Reuters
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 97%

Education Education Headlines News

Education Education Latest News,Education Education Headlines

Brazil's health regulator Anvisa has approved human clinical trials for a potential coronavirus vaccine developed by scientists at Oxford University and supported by AstraZeneca Plc, it said on Wednesday.

FILE PHOTO: Small bottles labeled with a"Vaccine COVID-19" sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

With COVID-19 epidemics in Britain, mainland Europe and the United States coming down from their peak and transmission rates of the coronavirus dropping, scientists have turned to places like Brazil, where the disease is still rife, to test potential vaccines. “This is a randomized controlled phase III study to determine the safety, efficacy ... of the non-replicating ChAdOx1 nCoV-19 vaccine,” Anvisa said in a statement announcing the approval of the clinical tests. “Initial non-clinical studies in animals and phase I clinical studies in humans to evaluate the safety of the vaccine were carried out in England and the results demonstrated that its safety profile was acceptable.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

I feel like a guinea pig

Don't need one this is more effective 10x+ higher mortality rate with low levels Low levels = broken respiratory immune system Normal levels = healthy respiratory immune system Findings Educational

I don't think it's for real... everyone is claiming to make a cure

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in EDUCATİON

Education Education Latest News, Education Education Headlines